Breakthroughs in Melanoma Research 2011
DOI: 10.5772/21339
|View full text |Cite
|
Sign up to set email alerts
|

Genomics of Human Malignant Melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2012
2012
2014
2014

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 59 publications
0
4
0
Order By: Relevance
“…CM tumorigenesis is often explained as a progressive transformation of normal melanocytes to nevi that subsequently develop into primary cutaneous melanomas (PCM). However, the molecular pathways involved have not been clearly elucidated, although considerable progress has been made [ 10 ]. Despite the success of genomics in defining genomic markers or gene signatures for other kinds of cancers (such as breast cancer), there has been no similar progress related to malignant melanoma.…”
Section: Background and Related Workmentioning
confidence: 99%
“…CM tumorigenesis is often explained as a progressive transformation of normal melanocytes to nevi that subsequently develop into primary cutaneous melanomas (PCM). However, the molecular pathways involved have not been clearly elucidated, although considerable progress has been made [ 10 ]. Despite the success of genomics in defining genomic markers or gene signatures for other kinds of cancers (such as breast cancer), there has been no similar progress related to malignant melanoma.…”
Section: Background and Related Workmentioning
confidence: 99%
“…CM tumorigenesis is often explained as a progressive transformation of normal melanocytes to nevi that subsequently develop into primary cutaneous melanomas. The molecular pathways involved have been although little studied [6] and despite that genomic markers or gene signatures have been defined for various cancers (such as breast cancer), there has been no similar progress for malignant melanoma. Genomic studies that have been performed on CM exploit different microarray technological platforms applied in highly heterogeneous patient sets.…”
Section: Cutaneous Melanomamentioning
confidence: 99%
“…CM tumorigenesis is often explained as a progressive transformation of normal melanocytes to nevi that subsequently develop into primary cutaneous melanomas (PCM). However, the molecular pathways involved have not been clearly elucidated, although considerable progress has been made [7]. Despite the success of genomics in defining genomic markers or gene signatures for other kinds of cancers (such as breast cancer), there has been no similar progress related to malignant melanoma.…”
Section: Cutaneous Melanomamentioning
confidence: 99%